CAS NO: | 1448221-67-7 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | Emactuzumab(RG 7155) is a specificmonoclonal antibodythat inhibits colonystimulating factor 1 receptor(CSF1R)activation. Emactuzumab has high affinity for CSF-1R withKivalue of 0.2 nM to blocks CSF-1R dimerization. Emactuzumab can be used for the research of several diseases, such as diffuse-type tenosynovial giant cell tumour (dt-GCT)[1][2]. | ||||||||
IC50& Target | IC50: 0.2 nM (CSF-1R)[2] | ||||||||
体外研究 (In Vitro) | Emactuzumab (RG 7155) binds to human and cynomolgus CSF-1R with high affinity (Kd= 0.2 nM) to blocks CSF-1R dimerization[2]. Cell Viability Assay[2]
| ||||||||
体内研究 (In Vivo) | Emactuzumab(RG 7155) (i.v.; 0.1、1、10、30 and 100 mg/kg; once) increases CSF-1 concentration in nonhuman primates’ peripheral blood[2].
| ||||||||
Clinical Trial | |||||||||
性状 | Liquid | ||||||||
CAS 号 | 1448221-67-7 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |